Paclitaxel-loaded lipid nanoparticles prepared by solvent injection or ultrasound emulsification

Drug Development and Industrial Pharmacy

Volumn 32, Issue 9, 2006, Pages 1089-1094

  Yegin, Betül Arica ^a   Benoît, Jean Pierre ^b   Lamprecht, Alf ^c,d  

^a HACETTEPE UNIVERSITY   (Turkey)

^b UNIVERSITÉ D'ANGERS   (France)

^c UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^d NONE   (France)

Author keywords

Lipid nanoparticles; Paclitaxel; Solvent injection; Sucrose fatty acid ester; Ultrasound emulsification

Indexed keywords

EMULSIFYING AGENT; LIPID; NANOPARTICLE; PACLITAXEL; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; SOLVENT; SUCROSE ESTER DERIVATIVE;

ARTICLE; ATOMIC FORCE MICROSCOPY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; DRUG RELEASE; EMULSION; INJECTION; PARTICLE SIZE; ULTRASOUND;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CALORIMETRY, DIFFERENTIAL SCANNING; EMULSIONS; ESTERS; FATTY ACIDS; NANOPARTICLES; PACLITAXEL; PARTICLE SIZE; PHOSPHATIDYLCHOLINES; SUCROSE; SURFACE-ACTIVE AGENTS; TECHNOLOGY, PHARMACEUTICAL; ULTRASONICS;

EID: 33749482136     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040600683501     Document Type: Article

References (24)

1. Arica, B., & Lamprecht, A. (2005). In-vitro evaluation of betamethasone loaded nanoparticles. Drug Development and Industrial Pharmacy, 31, 19-25.
2. Attawia, M. A., Borden, M. D., Herbert, K. M., Katti, D. S., Asrari, F., Uhrich, K. E., & Laurencin, C. T. (2001). Regional drug delivery with radiation for the treatment of Ewing's sarcoma. In vitro development of a taxol release system. Journal of Controlled Release, 71, 193-202.
3. Barichello, J. M., Morishita, M., Takayama, K., & Nagai T. (1999). Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method. Drug Development and Industrial Pharmacy, 25, 471-476.
4. Cavalli, R., Aquilano, D., Carrlotti, M. E., & Gasco, M. R. (1995). Study by X-ray powder diffraction and differential scanning calorimetry of two model drugs, phenothiazine and nifedipine, incorporated into lipid nanoparticles. European Journal of Pharmaceutics & Biopharmaceutics, 41, 329-333.
5. Cavalli, R., Caputo, O., & Gasco, M. R. (2000). Preparation and characterization of solid lipid nanospheres containing paclitaxel. European Journal of Pharmaceutical Sciences, 10, 305-309.
6. Cavalli, R., Gasco, M. R., Barresi, A. A., & Rovero, G. (2001). Evaporative drying of aqueous dispersions of solid lipid nanoparticles. Drug Development and Industrial Pharmacy, 27, 919-924.
7. Chen, D. B., Yang, T. Z., Lu, W. L., & Zhang, Q. (2001). In vitro and in vivo study of two types of long-circulating solid lipid nanoparticles containing paclitaxel. Chemical Pharmaceutical Bulletin, 49, 1444-1447.
8. Clas, S. D., Dalton, C. R., & Hancock, B. C. (1999). Differential scanning calorimetry: applications in drug development, Pharmaceutical Science Technology Today, 2, 311-320.
9. Garcia-Fuentes, M., Torres, D., Martin-Pastor, M., & Alonso, M. J. (2004). Application of NMR spectroscopy to the characterization of PEG-stabilized lipid nanoparticles. Langmuir, 20, 8839-8845.
10. Hou, D., Xie, C., Huang, K., & Zhu, C. (2003). The production and characteristics of solid lipid nanoparticles (SLNs). Biomaterials, 24, 1781-1785.
11. Jenning, V., Lippacher, A., & Gohla, S. H. (2002). Medium scale production of solid lipid nanoparticles (SLN) by high pressure homogenization. Journal of Microencapsulation, 19, 1-10.
12. Lamprecht, A., Ubrich, N., Yamamoto, H., Schäfer, U., Takeuchi, H., Lehr, C. M., Maincent, P., & Kawashima, Y. (2001). Design of rolipram loaded nanoparticles: comparison of two preparation methods. Journal of Controlled Release, 71, 297-306.
13. Langguth, P., Hanafy, A., Frenzel, D., Grenier, P., Nhamias, A., Ohlig, T., Vergnault, G., & Spahn-Langguth, H. (2005). Nanosuspension formulations for low-soluble drugs: pharmacokinetic evaluation using spironolactone as model compound. Drug Development and Industrial Pharmacy, 31, 319-329.
14. Liu, J., Zhu, J., Du, Z., & Qin, B. (2005). Preparation and pharmacokinetic evaluation of Tashinone IIA solid lipid nanoparticles. Drug Development and Industrial Pharmacy, 31, 551-556.
15. Miglietta, A., Cavalli, R., Bocca, C., Gabriel, L., & Gasco, M. R. (2000). Cellular uptake and cytotoxicity of solid lipid nanospheres (SLN) incorporating doxorubicin or paclitaxel. International Journal of Pharmaceutics, 210, 61-67.
16. Quintanar-Guerrero, D., Allémann, E., Doelker, E., & Fessi, H. (1997). A mechanistic study of the formation of polymer nanoparticles by the emulsification-diffusion technique. Colloid Polymer Science, 275, 640-647.
17. Schubert, M. A., & Müller-Goymann, C. C. (2003). Solvent injection as a new approach for manufacturing lipid nanoparticles: evaluation of the method and process parameters. European Journal of Pharmaceutics & Biopharmaceutics, 55, 125-131.
18. Serpe, L., Catalano, M. G., Cavalli, R., Ugazio, E., Bosco, O., Canaparo, R., Muntoni, E., Frairia, R., Gasco, M. R., Eandi, M., & Zara, G. P. (2004). Cytotoxicity of anticancer drugs incorporated in solid lipid nanoparticles on HT-29 colorectal cancer cell line. European Journal of Pharmaceutics & Biopharmaceutics, 58, 673-680.
19. Shirazi, F. H., Bahrami, G., Stewart, D. J., Tomiak, E., Delorme, F., Noel, D., & Goel, R. (2001). A rapid reversed phase high performance liquid chromatographic method for determination of PX (VP-16) in human plasma. Journal of Pharmaceutical and Biomedical Analysis, 25, 353-356.
20. Singla, A. K., Garg, A., & Aggarwal, D. (2002). Paclitaxel and its formulations. International Journal of Pharmaceutics, 235, 179-192.
21. Yang, S. C., & Zhu, J. B. (2002). Preparation and characterization of camptothecin solid lipid nanoparticles. Drug Development and Industrial Pharmacy, 28, 265-274.
22. Youan, Bi-Botti C., Hussain, A., & Nguyen, N. T. (2003). Evaluation of sucrose esters as alternative surfactants in microencapsulation of proteins by the solvent evaporation method. AAPS Pharm Sci. 5, Article 22.
23. Zhao, L., & Feng, S. S. (2005). Effects of lipid chain unsaturation and headgroup type on molecular interactions between paclitaxel and phospholipid within model biomembrane. Journal of Colloid and Interface Science, 285, 326-335.
24. Zhao, L., Feng, S. S., & Go, M. L. (2004). Investigation of molecular interactions between paclitaxel and DPPC by Langmuir film balance and differential scanning calorimetry. Journal of Pharmaceutical Sciences, 93, 86-98.